InnovAge Holding Corp. Amortization of Debt Issuance Costs
InnovAge Holding Corp. (INNV) reported Amortization of Debt Issuance Costs of $400.00 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2022-09-13
- InnovAge Holding Corp. amortization of debt issuance costs for the quarter ending 2021-09-30 was $100.00K.
- InnovAge Holding Corp. amortization of debt issuance costs for the quarter ending 2021-06-30 was -$1.00M.
- InnovAge Holding Corp. amortization of debt issuance costs for fiscal 2022 was $400.00K, a 63.64% decline from fiscal 2021.
- InnovAge Holding Corp. amortization of debt issuance costs for fiscal 2021 was $1.10M, a 83.33% increase from fiscal 2020.
- InnovAge Holding Corp. amortization of debt issuance costs for fiscal 2020 was $600.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-06-30 | $400.00K 10-K · filed 2022-09-13 | |||
| 2021-09-30 | $100.00K 10-Q · filed 2021-11-09 | -$900.00K derived: sum of 2 quarters · filed 2022-09-13 | ||
| 2021-06-30 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $1.10M 10-K · filed 2022-09-13 | ||
| 2021-03-31 | $2.10M 10-Q · filed 2021-05-11 | |||
| 2020-06-30 | $600.00K 10-K · filed 2021-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |